NCT04437264

Brief Summary

Evaluate effective delivery of goal nutrition with intermittent as compared with continuous enteral nutrition schedules, as defined by percentage of recommended calories that patient receives per day of interest.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 18, 2020

Completed
19 days until next milestone

Study Start

First participant enrolled

July 7, 2020

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2022

Completed
Last Updated

March 3, 2025

Status Verified

February 1, 2025

Enrollment Period

2.4 years

First QC Date

May 19, 2020

Last Update Submit

February 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Recommended calories

    percentage of recommended calories that patient receives per day of interest during study period

    Intubation day 1 to intubation day 10

Secondary Outcomes (8)

  • Percentage of patients with aspiration

    Intubation day 1 to intubation day 10

  • Percentage of patients experiencing intolerance of feeding

    Intubation day 1 to intubation day 10

  • feasibility: proportion complete protocol

    Intubation day 1 to intubation day 10

  • delirium

    intubation day 1 until 14 days later

  • urine 6-sulfatoxymelatonin acrophase

    day 1 to 3 following initiation of feeds

  • +3 more secondary outcomes

Study Arms (2)

Intermittent feed

EXPERIMENTAL

Patients will be assigned to receive intermittent enteral feeding protocol. They will receive four equal volume feeds at 8:00, 12:00, 16:00, and 20:00 hours.

Dietary Supplement: Intermittent feed participant

Continuous feeds

EXPERIMENTAL

Patients will be assigned to receive continuous enteral feeding protocol. Typical goal rates are in the range of 60 to 80 mL per hour for 24 hours per day.

Dietary Supplement: Continuous feeds participant

Interventions

Patients will be assigned to receive intermittent enteral feeding protocol. They will receive four equal volume feeds at 8:00, 12:00, 16:00, and 20:00 hours.

Intermittent feed

Patients will be assigned to receive continuous enteral feeding protocol. Typical goal rates are in the range of 60 to 80 mL per hour for 24 hours per day.

Continuous feeds

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • MICU Yale New Haven Hospital
  • Age \>= 18 years old.
  • Patients mechanically ventilated via endotracheal tube
  • Patients intubated within 72 hours of hospital admission
  • First intubation of current hospitalization
  • First MICU admission of current hospitalization

You may not qualify if:

  • Patient has opted out of research participation via institutional patient portal.
  • At significant risk for gastrointestinal intolerance of intermittent bolus feeds:
  • Structural gastrointestinal obstruction (such as tumor).
  • Chronic enteral nutrition (prior to current admission).
  • History of significant esophageal dysmotility (history of GERD is acceptable) or clinically significant GE junction incompetence
  • Unable to have head of bed elevated at least 30 degrees while intubated and being fed (this is standard protocol).
  • History of small bowel obstruction or ileus on current admission or within last 1 month.
  • History of gastroparesis.
  • Percutaneous gastrostomy tube or tracheostomy.
  • History of ongoing aspiration as determined by a speech medicine specialist or other medical professional or a patent who required adjustment of diet (e.g., thickening of liquids) prior to hospitalization.
  • History of significant esophageal dysmotility (history of GERD is acceptable) or clinically significant GE junction incompetence
  • At risk of refeeding syndrome.
  • Pregnant patients.
  • Patients receiving neuromuscular blockade.
  • Patients with glycemic emergency (HHNK, DKA, severe hypoglycemia resulting in MICU admission) or patients controlling their sugar / insulin dosing via continuous glucose monitoring
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale New Haven Hospital, York Street Campus

New Haven, Connecticut, 06520, United States

Location

MeSH Terms

Conditions

Nutrition Disorders

Condition Hierarchy (Ancestors)

Nutritional and Metabolic Diseases

Study Officials

  • Melissa P Knauert, MD, PhD

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The care team and study staff in the ICU will be aware of arm assignment. Study staff abstracting outcome data will be blinded to arm assignement.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2020

First Posted

June 18, 2020

Study Start

July 7, 2020

Primary Completion

December 7, 2022

Study Completion

December 7, 2022

Last Updated

March 3, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

De-identified individual participant data can be made available upon request.

Locations